HBK Investments’s West Pharmaceutical WST Stock Holding History

HBK Investments’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,500	Closed	-$330K	–	1056
2014 Q1	$330K	Buy	+7,500	New	+$353K	0.01%	763

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HBK Investments's WST Position: Q2 2014 in Review

HBK Investments sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 7,500 shares — an estimated $330K sold.

HBK Investments first reported a position in WST in Q1 2014 and held it in 1 quarter. The position peaked at $330K in Q1 2014. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

HBK Investments reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
HBK Investments sold 7,500 West Pharmaceutical shares in Q2 2014, an estimated $330K.
HBK Investments first reported a position in West Pharmaceutical in Q1 2014 and held it in 1 quarter.
HBK Investments's West Pharmaceutical position peaked at $330K in Q1 2014.
222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on HBK Investments's 13F filing for Q2 2014, filed 14 Aug 2014.